Predicting tuberculosis risk

The Lancet

Volumn 388, Issue 10057, 2016, Pages 2233-

  Kik, Sandra V ^a,b   Cobelens, Frank ^a,b   Moore, David ^c  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

BLOOD; HUMAN; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; LETTER; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RISK; RISK FACTOR;

HUMANS; MYCOBACTERIUM TUBERCULOSIS; RISK; RISK FACTORS; TUBERCULOSIS;

EID: 84994591195     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)32070-0     Document Type: Letter

References (2)

1. 1 Zak, DE, Penn-Nicholson, A, Scriba, TJ, et al., for the ACS and GC6-74 cohort study groups. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387 (2016), 2312–2322.
2. 2 Mahomed, H, Hawkridge, T, Verver, S, et al., on behalf of the SATVI Adolescent Study Team. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis 15 (2011), 331–336.